The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes

The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes

Aims: Between 11 to 14% of patients with locally advanced rectal cancer (LARC) have positive lateral pelvic lymph nodes (LPLN) at diagnosis, related to a worse prognosis with a 5-year survival rate between 30 to 40%. The best treatment choice for this group of patients is still a challenge. The opti...

Full description

Bibliographic Details
Main Authors: Elisa Meldolesi, Giuditta Chiloiro, Roberta Giannini, Roberta Menghi, Roberto Persiani, Barbara Corvari, Claudio Coco, Stefania Manfrida, Carlo Ratto, Viola De Luca, Luigi Sofo, Sara Reina, Antonio Crucitti, Valeria Masiello, Nicola Dinapoli, Vincenzo Valentini, Maria Antonietta Gambacorta
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
locally advanced rectal cancer
lateral pelvic positive nodes
radiotherapy
simultaneous integrated boost
chemoradiotherapy
Online Access:https://www.mdpi.com/2072-6694/14/7/1643

Internet

https://www.mdpi.com/2072-6694/14/7/1643

Similar Items